Half-year report 2024

Consolidated statement of changes in equity

January 1 – June 30

 

 

 

 

Attributable to shareholders of medmix Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2023

 

 

 

0.4

 

540.3

 

–12.5

 

0.7

 

–24.1

 

504.8

 

–

 

504.8

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

7.3

 

 

 

 

 

 

 

7.3

 

–

 

7.3

– Cash flow hedges, net of tax

 

 

 

–

 

–

 

–

 

0.6

 

–

 

0.6

 

–

 

0.6

– Remeasurements of defined benefit plans, net of tax

 

 

 

–

 

–0.3

 

–

 

–

 

–

 

–0.3

 

–

 

–0.3

– Currency translation differences

 

 

 

–

 

–

–

–

–

–

–

–3.2

 

–3.2

 

–

 

–3.2

Other comprehensive income

 

 

 

–

 

–0.3

 

–

 

0.6

 

–3.2

 

–2.9

 

–

 

–2.9

Total comprehensive income for the period

 

 

 

–

 

7.0

 

–

 

0.6

 

–3.2

 

4.4

 

–

 

4.4

Sale of investments in subsidiaries

 

 

 

–

 

–1.7

 

–

 

–

 

–

 

–1.7

 

–

 

–1.7

Contribution to the Sulzer group

 

8

 

–

 

–0.3

 

–

 

–

 

–

 

–0.3

 

–

 

–0.3

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

8

 

–

 

–0.4

 

0.4

 

–

 

–

 

–

 

–

 

–

Purchase of treasury shares

 

8

 

–

 

–

 

–1.0

 

–

 

–

 

–1.0

 

–

 

–1.0

Share-based payments

 

 

 

–

 

1.1

 

–

 

–

 

–

 

1.1

 

–

 

1.1

Dividends

 

8

 

–

 

–20.5

 

–

 

–

 

–

 

–20.5

 

–

 

–20.5

Equity as of June 30, 2023

 

 

 

0.4

 

525.7

 

–13.1

 

1.3

 

–27.3

 

486.9

 

–

 

486.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2024

 

 

 

0.4

 

529.8

 

–15.2

 

–0.9

 

–48.7

 

465.4

 

9.0

 

474.3

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

5.2

 

 

 

 

 

 

 

5.2

 

0.4

 

5.6

– Cash flow hedges, net of tax

 

 

 

–

 

–

 

–

 

–2.6

 

–

 

–2.6

 

–

 

–2.6

– Remeasurements of defined benefit plans, net of tax

 

 

 

–

 

0.9

 

–

 

–

 

–

 

0.9

 

–

 

0.9

– Currency translation differences

 

 

 

–

 

–

–

–

–

–

–

15.6

 

15.6

 

0.4

 

16.0

Other comprehensive income

 

 

 

–

 

0.9

 

–

 

–2.6

 

15.6

 

13.9

 

0.4

 

14.3

Total comprehensive income for the period

 

 

 

–

 

6.1

 

–

 

–2.6

 

15.6

 

19.1

 

0.8

 

19.9

Sale of investments in subsidiaries

 

 

 

–

 

–0.2

 

–

 

–

 

–

 

–0.2

 

–

 

–0.2

Put option liability

 

8

 

–

 

–3.2

 

–

 

–

 

–

 

–3.2

 

–

 

–3.2

Contribution to the Sulzer group

 

8

 

–

 

–0.1

 

–

 

–

 

–

 

–0.1

 

–

 

–0.1

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

8

 

–

 

–1.1

 

1.1

 

–

 

–

 

–

 

–

 

–

Purchase of treasury shares

 

8

 

–

 

–

 

–0.5

 

–

 

–

 

–0.5

 

–

 

–0.5

Share-based payments

 

 

 

–

 

0.8

 

–

 

–

 

–

 

0.8

 

–

 

0.8

Dividends

 

8

 

–

 

–20.4

 

–

 

–

 

–

 

–20.4

 

–

 

–20.4

Equity as of June 30, 2024

 

 

 

0.4

 

511.6

 

–14.6

 

–3.6

 

–33.0

 

460.8

 

9.8

 

470.6